speb/financial-data huggingface dataset:
OXY income_statement (quarterly, 2026-03-31) — Write Off: 120000000.00
OXY.TO balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -35000000.00
OXY.TO balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 72000000.00
OXY.TO cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -119000000.00
OXY.TO income_statement (annual, 2021-12-31) — Earnings From Equity Interest: 631000000.00
OXY.TO cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -192000000.00
OXY.TO cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -192000000.00
OXY.TO income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 122000000.00
OXY.TO balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 4243000000.00
OXY.TO cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 763000000.00
OXY.TO balance_sheet (annual, 2021-12-31) — Inventories Adjustments Allowances: -99000000.00
OXY.TO balance_sheet (annual, 2021-12-31) — Non Current Accounts Receivable: 1231000000.00
OXY.TO balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 7000000.00
OXY.TO income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -1065000000.00
OXY.TO cash_flow (annual, 2021-12-31) — Purchase Of Business: -431000000.00
OXY.TO balance_sheet (annual, 2021-12-31) — Restricted Cash: 24000000.00
OXY.TO income_statement (annual, 2022-12-31) — +Operating Expense: 3980000000.00
OXY.TO income_statement (annual, 2022-12-31) — +Total Revenue: 36634000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 4029000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 4281000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -62350000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 17181000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -37000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
OXY.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 3064276289.00
OXY.TO income_statement (annual, 2022-12-31) — Basic EPS: 4.05
OXY.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2803000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -4497000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -4497000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1619000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 9982000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 984000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 984000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1184000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -13715000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -4872000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 16810000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: 0.00
OXY.TO cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: 0.00
OXY.TO cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 0.00
OXY.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -230000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -335000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -185000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -478000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -432000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -1325000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -97000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -1777000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Common Stock: 220000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 20323000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 293000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -3099000000.00
OXY.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 18989000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 3290000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Current Assets: 8886000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 416000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Current Debt: 22000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 438000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 7757000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -1644000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -1644000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 6926000000.00
OXY.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 3315055972.00
OXY.TO income_statement (annual, 2022-12-31) — Diluted EPS: 3.75
OXY.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 12421000000.00
OXY.TO income_statement (annual, 2022-12-31) — EBIT: 15147000000.00
OXY.TO income_statement (annual, 2022-12-31) — EBITDA: 22073000000.00
OXY.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 793000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -219000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Employee Benefits: 1055000000.00
OXY.TO cash_flow (annual, 2022-12-31) — End Cash Position: 1026000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -13715000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Finished Goods: 1147000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 12313000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -308000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -308000000.00
OXY.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 308000000.00
OXY.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 317000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 195000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 4318000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 121637000000.00
OXY.TO income_statement (annual, 2022-12-31) — Gross Profit: 17645000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 2184000000.00
OXY.TO income_statement (annual, 2022-12-31) — Interest Expense: 1030000000.00
OXY.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1030000000.00
OXY.TO income_statement (annual, 2022-12-31) — Interest Income: 153000000.00
OXY.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 153000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1425000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -121000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Inventory: 2059000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 39469000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -4872000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 3176000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 293000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 400000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1203000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 19124000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 20327000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 400000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -9884000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 3176000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 4541000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
OXY.TO income_statement (annual, 2022-12-31) — Minority Interests: 0.00
OXY.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -116000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -2806000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Net Debt: 18162000000.00
OXY.TO income_statement (annual, 2022-12-31) — Net Income: 13304000000.00
OXY.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 12421000000.00
OXY.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 13304000000.00
OXY.TO income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
OXY.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 13304000000.00
OXY.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 13304000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 13304000000.00
OXY.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 13304000000.00
OXY.TO income_statement (annual, 2022-12-31) — Net Interest Income: -877000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -9484000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -9484000000.00
OXY.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -877000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -241000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -259000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Net PPE: 59287000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
OXY.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 30085000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 1260000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 5512000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 5512000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1055000000.00
OXY.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 21537000000.00
OXY.TO income_statement (annual, 2022-12-31) — Normalized Income: 12800160000.00
OXY.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 16810000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -527000000.00
OXY.TO income_statement (annual, 2022-12-31) — Operating Income: 13665000000.00
OXY.TO income_statement (annual, 2022-12-31) — Operating Revenue: 36234000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 899858944.00
OXY.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 1562000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 22000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 195000000.00
OXY.TO income_statement (annual, 2022-12-31) — Other Income Expense: 1329000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 76000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1260000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 3332000000.00
OXY.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -1271000000.00
OXY.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 1487000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Other Properties: 121637000000.00
OXY.TO income_statement (annual, 2022-12-31) — Other Taxes: 1548000000.00
OXY.TO income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 83000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Payables: 4029000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 7319000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Preferred Stock: 9762000000.00
OXY.TO income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 800000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 9762000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
OXY.TO income_statement (annual, 2022-12-31) — Pretax Income: 14117000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -990000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 1033000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Receivables: 4281000000.00
OXY.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 18989000000.00
OXY.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 6926000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -9884000000.00
OXY.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -3099000000.00
OXY.TO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 89000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 16499000000.00
OXY.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 945000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Share Issued: 1098512626.00
OXY.TO income_statement (annual, 2022-12-31) — Special Income Charges: 219000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 30085000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 20323000000.00
OXY.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 32160000.00
OXY.TO income_statement (annual, 2022-12-31) — Tax Provision: 813000000.00
OXY.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.06
OXY.TO balance_sheet (annual, 2022-12-31) — Total Assets: 72609000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 49209000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Total Debt: 20765000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 30085000000.00
OXY.TO income_statement (annual, 2022-12-31) — Total Expenses: 22969000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 42524000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 63723000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 34767000000.00
OXY.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 536000000.00
OXY.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 536000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 198653682.00
OXY.TO balance_sheet (annual, 2022-12-31) — Treasury Stock: 13772000000.00
OXY.TO balance_sheet (annual, 2022-12-31) — Working Capital: 1129000000.00
OXY.TO income_statement (annual, 2022-12-31) — Write Off: 0.00
OXY.TO income_statement (annual, 2023-12-31) — +Operating Expense: 3680000000.00
OXY.TO income_statement (annual, 2023-12-31) — +Total Revenue: 23156000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 3646000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 3195000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -68282000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 17422000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -29000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 209000000.00
OXY.TO income_statement (annual, 2023-12-31) — Average Dilution Earnings: 2000000.00
OXY.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 2941864042.00
OXY.TO income_statement (annual, 2023-12-31) — Basic EPS: 1.28
OXY.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1026000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -5696000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -5696000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1910000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 8509000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 1426000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1426000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1365000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -4886000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -6463000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 10235000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: -4000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: -517000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: 2073000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -84000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -13000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 66000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -423000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 581000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 140000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 931000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 438000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Common Stock: 222000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 21963000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 135000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -1798000000.00
OXY.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 14723000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1029000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Current Assets: 8375000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 592000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Current Debt: 1056000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1648000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 9148000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Current Provisions: 193000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 54000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Deferred Tax: 54000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 6449000000.00
OXY.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 3179079125.00
OXY.TO income_statement (annual, 2023-12-31) — Diluted EPS: 1.18
OXY.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 3752000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Dividends Payable: 307000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 902000000.00
OXY.TO income_statement (annual, 2023-12-31) — EBIT: 5193000000.00
OXY.TO income_statement (annual, 2023-12-31) — EBITDA: 11642000000.00
OXY.TO income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 534000000.00
OXY.TO income_statement (annual, 2023-12-31) — Earnings From Equity Interest Net Of Tax: 426000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 141000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Employee Benefits: 931000000.00
OXY.TO cash_flow (annual, 2023-12-31) — End Cash Position: 1464000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -4890000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Finished Goods: 1027000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 6612000000.00
OXY.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 522000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 275000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 3224000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 127941000000.00
OXY.TO income_statement (annual, 2023-12-31) — Gross Profit: 8433000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1299000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Income Tax Payable: 25000000.00
OXY.TO income_statement (annual, 2023-12-31) — Interest Expense: 957000000.00
OXY.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 957000000.00
OXY.TO income_statement (annual, 2023-12-31) — Interest Income: 153000000.00
OXY.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 153000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1017000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Interest Payable: 336000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -108000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Inventory: 2022000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 40964000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -6980000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 3224000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 135000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 283000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1318000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 17945000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 19263000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 283000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -351000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 3224000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 4771000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Minority Interest: 99000000.00
OXY.TO income_statement (annual, 2023-12-31) — Minority Interests: 0.00
OXY.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -479000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1663000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Net Debt: 17575000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Income: 4696000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 3750000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 3332000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 1364000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 4696000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 3332000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 4696000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 4696000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Interest Income: -804000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -68000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -68000000.00
OXY.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -804000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -129000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -288000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Net PPE: 59659000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: -1661000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 30250000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 5764000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 5764000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 931000000.00
OXY.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: 11355000000.00
OXY.TO income_statement (annual, 2023-12-31) — Normalized Income: 3122490000.00
OXY.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 12308000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -381000000.00
OXY.TO income_statement (annual, 2023-12-31) — Operating Income: 4753000000.00
OXY.TO income_statement (annual, 2023-12-31) — Operating Revenue: 23230000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 879463103.00
OXY.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 830000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 1056000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1382000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 275000000.00
OXY.TO income_statement (annual, 2023-12-31) — Other Income Expense: 287000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -932000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 2750000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1710000000.00
OXY.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -1084000000.00
OXY.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 1606000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Other Payable: 300000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Other Properties: 127941000000.00
OXY.TO income_statement (annual, 2023-12-31) — Other Taxes: 1087000000.00
OXY.TO income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 23000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Payables: 4896000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 5925000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Preferred Stock: 8287000000.00
OXY.TO income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 923000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 8287000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Preferred Stock Payments: -1661000000.00
OXY.TO income_statement (annual, 2023-12-31) — Pretax Income: 4236000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 1103000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Receivables: 4097000000.00
OXY.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 14723000000.00
OXY.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 6449000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -351000000.00
OXY.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -3459000000.00
OXY.TO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 26000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 19626000000.00
OXY.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 987000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Share Issued: 1107516500.00
OXY.TO income_statement (annual, 2023-12-31) — Special Income Charges: 287000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 30250000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 21963000000.00
OXY.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 77490000.00
OXY.TO income_statement (annual, 2023-12-31) — Tax Provision: 1330000000.00
OXY.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.27
OXY.TO balance_sheet (annual, 2023-12-31) — Total Assets: 74008000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 48195000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Total Debt: 20911000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 30349000000.00
OXY.TO income_statement (annual, 2023-12-31) — Total Expenses: 18403000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 43659000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 65633000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 34511000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 643000000.00
OXY.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 287000000.00
OXY.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 287000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 2072000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 228053397.00
OXY.TO balance_sheet (annual, 2023-12-31) — Treasury Stock: 15582000000.00
OXY.TO balance_sheet (annual, 2023-12-31) — Working Capital: -773000000.00
OXY.TO income_statement (annual, 2023-12-31) — Write Off: 209000000.00
OXY.TO balance_sheet (quarterly, 2024-09-30) — Allowance For Doubtful Accounts Receivable: -29000000.00
OXY.TO cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 21000000.00
OXY.TO income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: 1000000.00
OXY.TO cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: 73000000.00
OXY.TO income_statement (quarterly, 2024-09-30) — Earnings From Equity Interest: 166000000.00
OXY.TO balance_sheet (quarterly, 2024-09-30) — Employee Benefits: 933000000.00
OXY.TO balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 3953000000.00
OXY.TO balance_sheet (quarterly, 2024-09-30) — Inventories Adjustments Allowances: -108000000.00
OXY.TO cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
OXY.TO balance_sheet (quarterly, 2024-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 933000000.00
OXY.TO income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: -334000000.00
OXY.TO cash_flow (quarterly, 2024-09-30) — Preferred Stock Payments: 0.00
OXY.TO income_statement (annual, 2024-12-31) — +Operating Expense: 3593000000.00
OXY.TO income_statement (annual, 2024-12-31) — +Total Revenue: 22019000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 3472000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2839000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -65767000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 19868000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -24000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -24000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 355000000.00
OXY.TO cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 1260000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 1140000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 1140000000.00
OXY.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 3016634766.00
OXY.TO income_statement (annual, 2024-12-31) — Basic EPS: 0.78
OXY.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1464000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -6263000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -6263000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1596000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 8520000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2125000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2125000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1446000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3849000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -13821000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 10519000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: -5000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: -769000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: 920000000.00
OXY.TO cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: -200000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Change In Inventory: -27000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 472000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -540000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Change In Receivables: 170000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 75000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -116000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 693000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Common Stock: 233000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 25872000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 584000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -27000000.00
OXY.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 13728000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1036000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Current Assets: 9070000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 469000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Current Debt: 1003000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1472000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 9521000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Current Provisions: 388000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Current Provisions: 388000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -265000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -265000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 6951000000.00
OXY.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 3199591447.00
OXY.TO income_statement (annual, 2024-12-31) — Diluted EPS: 0.74
OXY.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 2364000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Dividends Payable: 354000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 354000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 720000000.00
OXY.TO income_statement (annual, 2024-12-31) — EBIT: 4434000000.00
OXY.TO income_statement (annual, 2024-12-31) — EBITDA: 11385000000.00
OXY.TO income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 862000000.00
OXY.TO income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 153000000.00
OXY.TO income_statement (annual, 2024-12-31) — Earnings From Equity Interest Net Of Tax: 759000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -83000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Employee Benefits: 1022000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Employee Benefits: 1022000000.00
OXY.TO cash_flow (annual, 2024-12-31) — End Cash Position: 2157000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 3844000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 537000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 5176000000.00
OXY.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: -16000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 179000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 3550000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 3550000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 132385000000.00
OXY.TO income_statement (annual, 2024-12-31) — Gross Profit: 8291000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1203000000.00
OXY.TO cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 391000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 471000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 471000000.00
OXY.TO income_statement (annual, 2024-12-31) — Interest Expense: 1169000000.00
OXY.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1169000000.00
OXY.TO income_statement (annual, 2024-12-31) — Interest Income: 192000000.00
OXY.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 192000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1052000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Interest Payable: 446000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Interest Payable: 446000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -93000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -93000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Inventory: 1756000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 51196000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -14590000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 2646000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 584000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 9612000000.00
OXY.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
OXY.TO balance_sheet (annual, 2024-12-31) — Liabilities Heldfor Sale Non Current: 333000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Liabilities Heldfor Sale Non Current: 333000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1127000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 24321000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 25448000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 9612000000.00
OXY.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
OXY.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -4514000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 2646000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 5682000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 321000000.00
OXY.TO income_statement (annual, 2024-12-31) — Minority Interests: -22000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -214000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 557000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Net Debt: 23199000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Income: 3056000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 2364000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 2866000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 212000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 3056000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 2844000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 3078000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 3078000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Interest Income: -977000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 5098000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 5098000000.00
OXY.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -977000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -360000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -7344000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Net PPE: 66618000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
OXY.TO cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
OXY.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 34159000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 5394000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 5394000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1022000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1022000000.00
OXY.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 11841000000.00
OXY.TO income_statement (annual, 2024-12-31) — Normalized Income: 3167760000.00
OXY.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 11439000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -23000000.00
OXY.TO income_statement (annual, 2024-12-31) — Operating Income: 4698000000.00
OXY.TO income_statement (annual, 2024-12-31) — Operating Revenue: 22710000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 938457983.00
OXY.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 490000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1003000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1499000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 1499000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 179000000.00
OXY.TO income_statement (annual, 2024-12-31) — Other Income Expense: -456000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 348000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 7111000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1361000000.00
OXY.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 1594000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Other Payable: 393000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Other Payable: 393000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Other Properties: 132385000000.00
OXY.TO income_statement (annual, 2024-12-31) — Other Taxes: 1039000000.00
OXY.TO income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 13000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Payables: 5126000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 6162000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Preferred Stock: 8287000000.00
OXY.TO income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 679000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 8287000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
OXY.TO cash_flow (quarterly, 2024-12-31) — Preferred Stock Payments: 0.00
OXY.TO income_statement (annual, 2024-12-31) — Pretax Income: 3265000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: -9117000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 1219000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Receivables: 3559000000.00
OXY.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 13728000000.00
OXY.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 6951000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -4514000000.00
OXY.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -27000000.00
OXY.TO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 84000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 21189000000.00
OXY.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 960000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Share Issued: 1166769167.00
OXY.TO income_statement (annual, 2024-12-31) — Special Income Charges: -456000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 34159000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 25872000000.00
OXY.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -132240000.00
OXY.TO income_statement (annual, 2024-12-31) — Tax Provision: 1158000000.00
OXY.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.29
OXY.TO balance_sheet (annual, 2024-12-31) — Total Assets: 85445000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 58480000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Total Debt: 26920000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 34480000000.00
OXY.TO income_statement (annual, 2024-12-31) — Total Expenses: 17321000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 50965000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 76375000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 41444000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 907000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 907000000.00
OXY.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -456000000.00
OXY.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -456000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 2204000000.00
OXY.TO balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 2204000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 228311184.00
OXY.TO balance_sheet (annual, 2024-12-31) — Treasury Stock: 15597000000.00
OXY.TO balance_sheet (annual, 2024-12-31) — Working Capital: -451000000.00
OXY.TO income_statement (annual, 2024-12-31) — Write Off: 356000000.00
OXY.TO income_statement (quarterly, 2024-12-31) — Write Off: 1260000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 886000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 5704000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3779000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3609000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -74117000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 19892000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -24000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
OXY.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 3114233719.00
OXY.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.24
OXY.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2157000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1682000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -1682000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1200000000.00